Established in 2004, Geeta Pharma LLC is a premier pharmaceutical supplier in Uzbekistan, serving as a strategic gateway for India’s largest manufacturers. Operating through a robust consortium of sister companies—including Florence Healthcare, Kohinoor Pharma, Positive Healthcare, and Hind Farm Group LS—the group delivers an expansive range of WHO-GMP and EU-GMP certified medicines across all major therapeutic segments. From advanced injectable and solid orals to novel delivery systems, Geeta Pharma combines state-of-the-art manufacturing with an agile distribution network to provide high-quality, affordable healthcare solutions throughout Central Asia.
Leveraging a high-performance consortium, our group companies offer an integrated and agile platform designed for rapid response to evolving market demands, complex regulatory frameworks, and urgent public health priorities. Pectro Biotech and its associates combine financial stability with operational excellence to deliver large-scale pharmaceutical solutions across the globe.
Under the distinguished leadership of Group Chairman Dr. Manmohan Bansal, Geeta Pharma LLC has emerged as a premier $35 Million USD enterprise, serving as a vital bridge between India’s advanced manufacturing sector and the healthcare landscapes of Central Asia and beyond. Demonstrating unparalleled operational scale, the group has successfully delivered and fulfilled high-stakes contracts valued at over $200 Million USD.
Dr. Manmohan Bansal’s expertise in regulatory compliance and financial analytics empowers our group to navigate global trade with agility. His proficiency in Hindi, English, and Russian has built enduring partnerships across Uzbekistan, Russia, the UAE, and Africa. By merging fiscal discipline with a patient-centric philosophy, the group sets international benchmarks in pharmaceutical precision.
By integrating a “Quality First” philosophy with a robust global supply chain, the group builds sustainable healthcare ecosystems ensuring that Precision in Every Formulation leads directly to Progress for Every Patient on a global scale.